Skip to main content
Log in

Vancomycin: Renewed interest in an old drag

  • Editorial
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Klimek, J., Marsik, F., Bartlett, R. C., Weir, B., Shea, P., Quintiliani, R.: Clinical, epidemiologic and bacteriologicStaphylococcus aureus in a large community hospital. American Journal of Medicine 1976, 61: 340–345.

    PubMed  Google Scholar 

  2. Crossley, K., Loesch, D., Landesman, B., Mead, K., Chern, M., Strate, R.: An outbreak of infections caused by strains ofStaphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. Journal of Infectious Diseases 1979, 139: 273–279.

    Google Scholar 

  3. Karchmer, A. W., Archer, G. L., Dismukes, W.:Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Annals of Internal Medicine 1983, 98: 477–485.

    Google Scholar 

  4. Farber, B. F., Moellering, R. C.: Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy 1983, 23: 138–141.

    PubMed  Google Scholar 

  5. Krogstad, D. J., Moellering, R. C., Greenblatt, D. J.: Single dose kinetics of intravenous vancomycin. Journal of Clinical Pharmacology 1980, 20: 197–201.

    PubMed  Google Scholar 

  6. Moellering, R. C., Krogstad, D. J., Greenblatt, D. J.: Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Annals of Internal Medicine 1981, 94: 343–346.

    PubMed  Google Scholar 

  7. Magera, B. E., Arroyo, J. C., Rosansky, S. J., Postic, B.: Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicobial Agents Chemotherapy 1983, 23: 710–714.

    Google Scholar 

  8. Moellering, R. C., Krogstad, D. J., Greenblatt, D. J.: Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. Reviews of Infectious Diseases 1981, 3: S. 230–235.

    Google Scholar 

  9. Farber, B. F., Karchmer, A. W., Buckley, M., Moellering, R. C.: Vancomycin prophylaxis during cardiac operations. Determination of an optimal dose. Journal of Thoracic and Cardiovascular Surgery 1983, 85: 933–935.

    PubMed  Google Scholar 

  10. Morris, A. J., Bilinsky, R. T.: Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. American Journal of Medical Science 1971, 262: 87–92.

    Google Scholar 

  11. American Heart Association Committee on Prevention of Bacterial Endocarditis: Prevention of bacterial endocarditis. Circulation 1977, 56: 139A.

    Google Scholar 

  12. Newfield, P., Rolzen, M. F.: Hazards of rapid administration of vancomycin. Annals Internal Medicine 1979, 89: 4.

    Google Scholar 

  13. Watanakunakorn, C.: Treatment of infections due to methicillin resistantStaphylococcus aureus. Annals of Internal Medicine 1982, 97: 376–378.

    PubMed  Google Scholar 

  14. Lowy, F. D., Chang, D. S., Lash, P. R.: Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin resistant coagulase negative staphylococci. Antimicrobial Agents and Chemotherapy 1983, 23: 932–934.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farber, B.B. Vancomycin: Renewed interest in an old drag. Eur. J, Clin. Microbiol. 3, 1–3 (1984). https://doi.org/10.1007/BF02032805

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02032805

Navigation